TrialNeuro-oncology2014

Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.

Ute Bartels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.